Finance

Beta
Lists
CING:NASDAQ
Cingulate Inc
$5.09
-3.96%
(-0.21) 1D
$5.01
-1.57% (-0.080)
Pre-market
Closed: Jul 7, 4:00:00 PM GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for CING...
Open
$5.30
High
$5.30
Low
$4.91
Mkt. cap
68.56M
Avg. vol.
672.80K
Volume
877.00
52-wk high
$11.89
52-wk low
$3.16
EPS
-$4.33
Beta
-0.91
Shares outstanding
13.47M
No. of employees
14
Open
$5.30
High
$5.30
Low
$4.91
Mkt. cap
68.56M
Avg. vol.
672.80K
Volume
877.00
52-wk high
$11.89
52-wk low
$3.16
EPS
-$4.33
Beta
-0.91
Shares outstanding
13.47M
No. of employees
14
News stories
From sources across the web
About Cingulate Inc
CEO-
Employees14
Founded2012
HeadquartersKansas City, Kansas, United States
SectorPharmaceutical industry
Websitecingulate.com
Analyst ratings
Based on 4 analysts giving stock ratings to CING in the past 3 months
Strong buy
Buy
4
Hold
0
Sell
0
12-month forecast
Based on 4 Wall Street analysts offering 12 month price targets for CING in the last 3 months.
Highest
Current $5.09
$52.00 (+921.61%)
Average
$22.50 (+342.04%)
Lowest
$8.00 (+57.17%)
Analyst
Recommendation
Action
Price target
Projected
Date
Edward Woo
Ascendiant
Buy
Maintained
$52.00
+921.6%
06/06/2026
Boobalan Pachaiyappan
Roth MKM
Buy
Maintained
$10.00
+96.5%
06/04/2026
Naz Rahman
Maxim Group
Buy
Reiterated
$8.00
+57.2%
06/03/2026
Ram Selvaraju
H.C. Wainwright
Buy
Reiterated
$20.00
+292.9%
05/26/2026
Previous reportsAll values in USD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in USD
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Revenue
-
-
-
-
Cost of goods sold
2.70M
2.85M
2.00M
2.18M
Cost of revenue
2.70M
2.85M
2.00M
2.18M
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
1.95M
3.15M
3.58M
5.74M
Operating expense
1.95M
3.15M
3.58M
5.74M
Total operating expenses
4.65M
6.00M
5.59M
7.92M
Operating income
-4.65M
-6.00M
-5.59M
-7.92M
Other non operating income
-
-772.17K
-133.99K
-852.03K
EBT including unusual items
-4.79M
-7.34M
-6.27M
-9.31M
EBT excluding unusual items
-4.79M
-7.34M
-6.27M
-9.31M
Income tax expense
-
-
-
-
Effective tax rate
-
-
-
-
Other operating expenses
-
-
-
-
Net income
-4.79M
-7.34M
-6.27M
-9.31M
Net profit margin
-
-
-
-
Earnings per share
-1.09
-1.35
-0.84
-0.95
Interest and investment income
-
-
369.27K
-
Interest expense
-138.76K
-573.06K
-921.92K
-536.84K
Net interest expenses
-138.76K
-573.06K
-552.66K
-536.84K
Depreciation and amortization charges
-
-
-
-
EBITDA
-4.50M
-5.89M
-5.46M
-7.80M
Gain or loss from assets sale
-
-
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer

Research

What's on your mind?
What's going on with the markets today?
Explore what’s possible
Create a task
Deep Search
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer